The product of a gas6 splice variant allows the release of the domain responsible for Axl tyrosine kinase receptor activation

被引:19
|
作者
Goruppi, S
Yamane, H
Marcandalli, P
Garcia, A
Clogston, C
Gostissa, M
Varnum, B
Schneider, C
机构
[1] LNCIB,LAB NAZL CONSORZIO INTERUNIV BIOTECNOL,I-34012 TRIESTE,ITALY
[2] UNIV UDINE,DIPARTIMENTO SCI & TECNOL BIOMED,I-33100 UDINE,ITALY
[3] AMGEN CORP,THOUSAND OAKS,CA
关键词
growth factor; receptor; vitamin K;
D O I
10.1016/S0014-5793(97)01093-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The product of gas6 (Gas6) is a growth factor with high level of similarity to protein S and was identified as the ligand for Axl family of tyrosine kinase receptors, Gas6 contains an N-terminal gamma-carboxylated domain (Gla), four epidermal growth factor like domains and a large C-terminal D region, An alternative Gas6 spliced form (Gas6SV) having an additional 43 amino acids between fourth EFG like and D domain was characterised, Here we show data indicating that Gas6SV is specifically cleaved within the inserted sequence, thereby splitting the D domain from the remaining part of the protein, The resulting two proteolytic products of 36 kDa and 50 kDa were separated and the 50 kDa fragment corresponding to region D was shown to be responsible for Axl receptor activation, Furthermore a deletion mutant of Gas6 containing only the D domain was shown to similarly activate Art receptor phosphorylation unequivocally demonstrating that D domain can act as a signalling molecule, The possible roles of the proteolytic processing of Gas6SV in the regulation of growth factor availability are discussed, (C) 1997 Federation of European Biochemical Societies.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 48 条
  • [41] Crystal structure of a C-terminal fragment of growth arrest-specific protein Gas6 -: Receptor tyrosine kinase activation by laminin G-like domains
    Sasaki, T
    Knyazev, PG
    Cheburkin, Y
    Göhring, W
    Tisi, D
    Ullrich, A
    Timpl, R
    Hohenester, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (46) : 44164 - 44170
  • [42] Tumor tissue and plasma levels of AXL and GAS6 before and after tyrosine kinase inhibitor treatment in EGFR-mutated non-small cell lung cancer
    Nonagase, Yoshikane
    Takeda, Masayuki
    Azuma, Koichi
    Hayashi, Hidetoshi
    Haratani, Koji
    Tanaka, Kaoru
    Yonesaka, Kimio
    Ishii, Hidenobu
    Hoshino, Tomoaki
    Nakagawa, Kazuhiko
    THORACIC CANCER, 2019, 10 (10) : 1928 - 1935
  • [43] Tyro3, Axl, MerTK-Receptor Activation by Gas6 or Pros1 Gene Delivery, ameliorates Collagen-induced arthritis
    van de Loo, Fons A. J.
    van den Brand, Ben T.
    Abdollahi-Roodsaz, Shahla
    Vermeij, Eline A.
    Bennink, Miranda B.
    Arntz, Onno J.
    van den Berg, Wim B.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S390 - S390
  • [44] Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes
    Ekman, Carl
    Linder, Adam
    Akesson, Per
    Dahlback, Bjorn
    CRITICAL CARE, 2010, 14 (04):
  • [45] Analysis of receptor tyrosine kinase genetics identifies two novel risk loci in GAS6 and PROS1 in Behcet's disease
    Qin, Jieying
    Li, Lin
    Zhang, Donglei
    Yu, Hongsong
    Tan, Handan
    Zhang, Jun
    Deng, Bolin
    Kijlstra, Aize
    Yang, Peizeng
    SCIENTIFIC REPORTS, 2016, 6
  • [46] Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes
    Carl Ekman
    Adam Linder
    Per Åkesson
    Björn Dahlbäck
    Critical Care, 14
  • [47] Analysis of receptor tyrosine kinase genetics identifies two novel risk loci in GAS6 and PROS1 in Behçet’s disease
    Jieying Qin
    Lin Li
    Donglei Zhang
    Hongsong Yu
    Handan Tan
    Jun Zhang
    Bolin Deng
    Aize Kijlstra
    Peizeng Yang
    Scientific Reports, 6
  • [48] The Gas6 receptor AxI enhances platelet activation responses through stimulation of P13kinase-and PLC-Dependent signaling pathways.
    Gould, WR
    Baxi, S
    Perrin, LA
    Leadley, RJ
    BLOOD, 2004, 104 (11) : 182A - 182A